Skip to main content
Premium Trial:

Request an Annual Quote

Frederico Monzon and Greg Schafer

Castle Biosciences has appointed Frederico Monson as chief financial officer and Greg Schafer as executive director of managed care. Monson most recently served as medical director of Oncology and medical director of Latin America at Invitae. Previously, he served in several successive roles at Baylor College of Medicine, including director of pathology at its Cancer Genetics Laboratory. Schafer most recently served as head of managed care at Invitae. Previously, he served as director of strategic markets and associate director of managed care at Genomic Health. Earlier in his career, Schafer served as business relations manager at Biogen and held sales management roles at Novartis and Zeneca Pharmaceuticals.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.